(IN BRIEF) Marks & Spencer (M&S) has revealed that retail is the leading first employer for young people in the UK, with one in four starting their careers in the industry. The company’s Marks & Start programme, developed with The … Read the full press release
(IN BRIEF) The International Federation of Gynecology and Obstetrics (FIGO) has selected Montréal, Canada, as the host city for the XXVI FIGO World Congress of Gynecology and Obstetrics, scheduled for 31 October–5 November 2027. Organised in partnership with the Society … Read the full press release
Posted in Healthcare, Management, News, Science, Society, United Kingdom
Tagged advocacy, CANADA, Clinicians, Diane Francoeur, FIGO, FIGO and SOGC Announce Montréal as Venue for 2027 Congress on Gynecology and Obstetrics, FIGO and SOGC to Host the 2027 World Congress of Gynecology and Obstetrics in Montréal, FIGO World Congress 2027, FIGO World Congress 2027 Heads to Montréal, Frank Louwen, global health, gynecology, Healthcare, inclusivity, INNOVATION, international collaboration, International Federation of Gynecology and Obstetrics, medical conference, Montréal, Montréal Selected as Host City for FIGO World Congress 2027 in Partnership with SOGC, Obstetrics, Palais des congrès de Montréal, policymakers, RESEARCH, scientific programme, Showcasing Global Leadership in Women’s Health, Society of Obstetricians and Gynaecologists of Canada, SOGC, sustainability, Women’s Health
(IN BRIEF) Siemens Smart Infrastructure has implemented its Building X platform at San Juan de Dios Hospital in Seville, Spain, making the facility a model for smart and sustainable healthcare operations. The AI-powered system integrates energy management, security, and HVAC … Read the full press release
Posted in Energy, Gas & Oil, Environment, Germany, Healthcare, Industrial, Infrastructure & Utilities, News, Spain, Technology, Transportation & Logistics
Tagged AI-based platform, Building Management System, Building X, carbon reduction, Delphine Clément, Desigo CC, digital building, energy efficiency, Energy Manager, facility optimization, healthcare digitalization, HVAC automation, María Jesús Pareja, Operations Manager, San Juan de Dios Hospital, security management, Seville, Siemens, Siemens Enables 35% Operational Cost Reduction at Spanish Hospital through Digital Building Integration, Siemens Partners with San Juan de Dios Hospital to Lead the Next Generation of Smart Healthcare Buildings, Siemens Smart Infrastructure, Siemens Transforms San Juan de Dios Hospital into a Smart, Siemens Xcelerator, Siveillance Suite, Smart Hospital, Spain, sustainability, Sustainable Facility with Building X
(IN BRIEF) A new study led by researchers at The Institute of Cancer Research, London, has identified a promising new combination therapy for pancreatic cancer that could transform future treatment. The dual approach — combining boiling histotripsy and oncolytic reovirus … Read the full press release
Posted in Business, Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged boiling histotripsy, cancer research, cancer treatment innovation, Gail ter Haar, ICR, ICR study identifies new immune-based combination strategy to improve pancreatic cancer treatment outcomes, immune response, immunotherapy, Institute of Cancer Research, macrophages, neutrophils, oncolytic reovirus, pancreatic cancer, Pancreatic cancer study from ICR highlights new dual treatment approach and reveals key immune cell insights, Pancreatic Cancer UK, Petros Mouratidis, Pharmaceutics, preclinical study, The Institute of Cancer Research identifies promising dual treatment strategy for pancreatic cancer, tumour microenvironment, ultrasound therapy, viral immunotherapy
(IN BRIEF) The Institute of Cancer Research has renewed its Athena Swan Silver Award for 2025–2029, recognising continued progress in promoting gender equality and fostering an inclusive workplace. The award highlights key achievements such as improved recruitment and flexible working … Read the full press release
Posted in Business, Education, Healthcare, Management, News, Pharma & Biotech, Science, Society, Technology, United Kingdom
Tagged academic leadership, Advance HE, Alan Cumber, and research culture, Athena Swan action plan, Athena Swan Silver Award, career development, diversity, Diversity And Inclusion, Dr Barbara Pittam, equity in research, flexible working, gender equality, Gender Pay Gap, higher education, ICR, ICR recognised for advancing inclusive excellence with Athena Swan Silver Award renewal through 2029, ICR secures four-year Athena Swan Silver Award recognising progress in equity, Institute of Cancer Research, Institute of Cancer Research celebrates renewed Athena Swan Silver Award with new gender equality action plan, Pathway to Independence program, Professor Christina Yap, Professor Kristian Helin, research culture, Technician Career Pathways
Europe’s RNA immunotherapy sector is gaining speed with new in vivo CAR-T and mRNA vaccine trials. Germany approved the region’s first in vivo CAR-T study, marking regulatory progress. The UK’s Cancer Vaccine Launch Pad advances personalised mRNA cancer vaccine trials … Read the full press release
Posted in Belgium, Business, Germany, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, ATMP, autoimmunity, BioNTech, BioNTech’s BNT116, biotechnology, Cancer Vaccine Launch Pad, CAR-T therapy, clinical trials, CREATE Medicines, CureVac, EMA, EU-FAB, Europe, Europe Becomes a Hub for Next-Generation RNA Immunotherapy with Strong Clinical and Industrial Momentum, Europe’s Biotech Sector Accelerates RNA-Based Immunotherapy with Breakthroughs in CAR-T and mRNA Vaccines, Europe’s RNA Immunotherapy Industry Poised for Expansion as BioNTech AstraZeneca and CREATE Medicines Lead Advances, Europe’s RNA Immunotherapy Landscape Expands with First In Vivo CAR-T Trial and Growing mRNA Vaccine Efforts, Europe’s RNA Immunotherapy Pipeline Gains Scale as Regulators and Industry Push for Next-Gen Cancer Treatments, fibrosis, Germany, Imfinzi, immuno-oncology, in vivo CAR-T, INT2104, mRNA Vaccines, multi-lineage immune programming, Myeloid Therapeutics, NHS England, oncology, pharma, RNA immunotherapy, RNA Immunotherapy in Europe: Emerging Trials Strategic Mergers and a Clearer Regulatory Path, RNA Immunotherapy Takes Hold in Europe as BioNTech-CureVac Deal and CREATE Medicines Expansion Signal Maturity, RNA therapeutics, RNA-based therapies, United Kingdom
Rebrand: Myeloid Therapeutics becomes CREATE Medicines, reflecting a shift to multi-lineage RNA immune programming. Scientific Focus: Expanding beyond myeloid cells to include T and NK cells for scalable, redosable in vivo CAR therapies. Clinical Data: Over 40 patients treated with … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Technology
Tagged 8VC, ARCH Venture Partners, autoimmunity, B-cell depletion, biopsies, Biotech, biotechnology, breast cancer, cancer therapy, CAR+ immune cells, CD8 T cell recruitment, clinical trials, CREATE Medicines, CREATE Medicines Bridges Science Strategy and Investment with Expanded RNA Platform for In Vivo Multi-Immune Therapies in Europe and Beyond, CREATE Medicines Integrates Scientific Progress and Investor Backing to Lead Multi-Lineage RNA Immunotherapy’s Next Chapter in Europe, CREATE Medicines Rebrand Reflects Strategic Expansion into Multi-Lineage RNA Immunotherapy as Europe’s Biotech Sector Embraces In Vivo Therapies, CREATE Medicines Reinforces Its Market and Research Focus Through RNA-Driven Multi-Lineage Immune Programming Amid Rising European Investment in mRNA Therapeutics, CREATE Medicines Strengthens Its Scientific and Strategic Position with Multi-Lineage RNA Platform and Investor Support Across a Growing European Biotech Market, CREATE Medicines’ New Identity Combines RNA-Based Scientific Leadership and Investor Momentum with Expanding Opportunities in European Immunotherapy Markets, CREATE Medicines’ Transition Marks New Phase in RNA Immunotherapy Development and Strategic Growth in Europe’s Expanding Biotech Landscape, Daniel Getts, Daniel Getts Ph.D., fibrosis, Following Its Rebrand, From Myeloid Therapeutics to CREATE Medicines: A Rebrand Uniting RNA Innovation Investor Confidence and Expanding European Immunotherapy Ambitions, GPC3, GPC3-positive solid tumors, GPC3; hepatocellular carcinoma, Hatteras Venture Partners, HER2, HER2 multi-immune CAR, HER2; solid tumors, himeric antigen receptor, immune cell reprogramming, immune cells, immune remodeling, immunotherapies, immunotherapy, in vivo CAR, in vivo CAR-T mediated B cell depletion, in vivo multi-immune programming, mRNA, mRNA-LNP platform, MT-302, MT-303, MT-304, multi-immune programming, multilineage immune programming, myeloid, myeloid cells, Myeloid Therapeutics, myeloid-focused in vivo programming, Newpath Partners, NK cell programming, NK cells, off-the-shelf therapies, oncology, Phase 1 studies, Rebranded CREATE Medicines Aligns Scientific Innovation and Investor Backing to Advance RNA-Based In Vivo CAR Therapies in Global and European Markets, Rebranded CREATE Medicines Positions Itself at the Forefront of RNA Immunotherapy as Europe’s Biotech Ecosystem Accelerates Innovation, retrotransposon-based CAR-T, RNA retrotransposon, RNA technology, RNA-based in vivo CAR therapeutics, RNA-based therapeutics, solid tumors, T cells, therapies, TROP2, TROP2; solid tumors, tumors, vivo CAR, vivo CAR-T
(IN BRIEF) AstraZeneca reported positive Phase III Bax24 trial results showing that baxdrostat achieved a significant and clinically meaningful reduction in 24-hour ambulatory systolic blood pressure in patients with treatment-resistant hypertension. The once-daily oral therapy was well tolerated and maintained … Read the full press release
Posted in Business, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Advancing Toward Regulatory Submission, AHA 2025, aldosterone, aldosterone synthase inhibitor, ambulatory blood pressure, American Heart Association, AstraZeneca, AstraZeneca’s Baxdrostat Achieves Significant Blood Pressure Reduction in Phase III Bax24 Trial, AstraZeneca’s Baxdrostat Achieves Strong Blood Pressure Reduction in Phase III Bax24 Trial for Resistant Hypertension, Bax24, Baxdrostat, Baxdrostat Delivers Significant 24-Hour Blood Pressure Control in Phase III Study, BaxHTN, Bryan Williams, cardiovascular health, Chronic kidney disease, clinical trial, heart failure prevention, Hypertension Treatment, Phase III results, primary aldosteronism, resistant hypertension, rHTN, SBP, Sharon Barr, systolic blood pressure
(IN BRIEF) FIGO has presented the 2025 FIGO Women’s Awards to nineteen exceptional women from around the world for their transformative contributions to gynaecology, obstetrics, and women’s health. The awards, announced during the FIGO General Assembly at the XXV FIGO … Read the full press release
Posted in Awards, Healthcare, Management, News, Science, Society, United Kingdom
Tagged Aisha Siddiqa, Amanda Black, Annettee Olivia Nakimuli, Cape Town, Cliona Murphy, Diana Ramašauskaitė, Elena Calle Texeira, Farhana Dewan, FIGO, FIGO Celebrates Excellence in Women’s Health with 2025 Awards Honouring Female Medical Innovators, FIGO General Assembly, FIGO Honours 19 Global Female Leaders with the 2025 Women’s Awards for Advancing Women’s Health, FIGO Women’s Awards 2025, FIGO Women’s Awards 2025 Highlight Global Leaders Shaping the Future of Obstetrics and Gynaecology, gender equality, global health, gynecology, Jackline Agel Akol, Jaideep Malhotra, Jane Hirst, Johanne Sundby, Kaori Koga, leadership, Linda Giudice, Liona Poon, Luz Marcela Celis Amórtegui, Ma. Corazon Zaida Gamilla, maternal health, Meliza Mejia, Obstetrics, reproductive health, Samia Ibrahim Esmeal, women in medicine, Women’s Health, XXV FIGO World Congress, Ya-Min Cheng
(IN BRIEF) The International Federation of Gynecology and Obstetrics (FIGO) has expanded its international network to 142 national societies with the inclusion of new members from Angola, Chad, and Guyana. These associations—Associação de Ginecologistas e Obstetras de Angola, Association Tchadienne … Read the full press release
Posted in Healthcare, Management, News, Science, Society, United Kingdom
Tagged Angola, Associação de Ginecologistas e Obstetras de Angola, Association Tchadienne des Gynécologues-Obstétriciens, Chad, Family Planning, FIGO, FIGO Grows to 142 National Societies with Addition of New Members Advancing Women’s Health Worldwide, FIGO membership, FIGO Welcomes New National Associations to Enhance Global Action for Women’s Health and Rights, Frank Louwen, gender equality, global health, Guyana, gynecology, healthcare access, International Federation of Gynecology and Obstetrics, maternal health, Obstetrics, reproductive health, The Guyana Obstetrics and Gynecology Society, women's rights, Women’s Health
(IN BRIEF) FIGO will host over 5,000 participants at the XXV FIGO World Congress of Gynecology and Obstetrics, held in Cape Town, South Africa, from 5–9 October 2025. Returning to Africa for the first time since 2009, the Congress will … Read the full press release
Posted in Awards, Healthcare, Management, News, Science, Society, United Kingdom
Tagged adolescent gynecology, Cape Town, climate change, endometriosis, FIGO, FIGO 2025 Congress Returns to Africa with Global Focus on Innovation Equity and Women’s Wellbeing, FIGO Film Festival, FIGO to Welcome Over 5000 Delegates to XXV World Congress in Cape Town to Advance Global Women’s Health, global health, gynecology, Health Equity, maternal health, menopause, migrant health, newborn health, Obstetrics, oncology, Over 5000 Health Leaders to Gather in Cape Town for FIGO 2025 to Champion Women’s and Girls’ Health, Professor Kihara Anne-Beatrice, Professor Paul Fogarty, reproductive health, reproductive rights, social justice, South Africa, SRHR, transgender care, Women’s Health, XXV FIGO World Congress
(IN BRIEF) At the XXIII FIGO World Congress of Gynecology and Obstetrics in Cape Town, six outstanding figures were honoured for their global impact on women’s health and rights. The FIGO Distinguished Merit Award was presented to Ethiopia’s Health Minister … Read the full press release
Posted in Awards, Healthcare, Management, News, Science, Society, United Kingdom
Tagged Afghanistan, Cape Town, Christine Solbach, ETHIOPIA, FIGO, FIGO World Congress in Cape Town Recognises Champions of Global Women’s Health and Empowerment, gender equality, Germany, global health, gynecology, health advocacy, HIV prevention, HPV vaccination, Japan, Jeannette Kagame, Linda-Gail Bekker, medical research, Mekdes Daba Feyssa, Obstetrics, reproductive health, Rwanda, Sima Samar, Six Global Leaders Honoured by FIGO for Outstanding Contributions to Women’s Health and Rights, South Africa, Tadashi Kimura, women's rights, Women’s Health, XXIII FIGO World Congress
CREATE Medicines (“CREATE”) broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune cells inside the human body, providing clear differentiation among competitors and significant value potential for all stakeholders CREATE Medicines will … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Technology
Tagged 8VC, ARCH Venture Partners, autoimmunity, B-cell depletion, biopsies, Biotech, biotechnology, breast cancer, cancer therapy, CAR+ immune cells, CD8 T cell recruitment, clinical trials, CREATE Medicines, Daniel Getts, Daniel Getts Ph.D., fibrosis, GPC3, GPC3-positive solid tumors, GPC3; hepatocellular carcinoma, Hatteras Venture Partners, HER2, HER2 multi-immune CAR, HER2; solid tumors, immune cell reprogramming, immune cells, immune remodeling, immunotherapies, immunotherapy, in vivo CAR, in vivo CAR-T mediated B cell depletion, in vivo multi-immune programming, mRNA, mRNA-LNP platform, MT-302, MT-303, MT-304, multi-immune programming, multilineage immune programming, myeloid, myeloid cells, Myeloid Therapeutics, myeloid-focused in vivo programming, Newpath Partners, NK cell programming, NK cells, off-the-shelf therapies, oncology, Phase 1 studies, retrotransposon-based CAR-T, RNA retrotransposon, RNA technology, RNA-based in vivo CAR therapeutics, RNA-based therapeutics, solid tumors, T cells, therapies, TROP2, TROP2; solid tumors, tumors, vivo CAR, vivo CAR-T
(IN BRIEF) The Institute of Cancer Research and NEOsphere Biotechnologies have announced a new collaboration to accelerate the discovery of molecular glue degrader drugs, an innovative approach in targeted cancer therapy. The partnership will integrate ICR’s proprietary molecular glue library … Read the full press release
Posted in Business, Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Academic–industry partnership to accelerate rational design of molecular glue degrader drugs for cancer treatment, artificial intelligence, Cancer Drug Discovery, cancer research innovation, Centre for Protein Degradation, computational drug design, E3 ligases, Henrik Daub, high-throughput proteomics, ICR, ICR and NEOsphere Biotechnologies join forces to pioneer systematic discovery of molecular glue degrader therapies, Institute of Cancer Research, Institute of Cancer Research and NEOsphere Biotechnologies partner to advance molecular glue degrader drug discovery, Jonathan Beech, Machine Learning, MGDs, molecular glue degraders, molecular glue library, Monte Rosa Therapeutics, Nature Communications, NEOsphere Biotechnologies, Novartis, proteomics, St Jude Children’s Research Hospital, targeted protein degradation, Zoran Rankovic
(IN BRIEF) bonprix, together with Brustkrebs Deutschland e. V., has launched its “Feel ahead!” campaign for Breast Cancer Awareness Month, highlighting the importance of breast self-examination with the striking image of a knotted bra. Running alongside the release of its … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Germany, Healthcare, Marketing, Media, News, Retail, Society
Tagged awareness campaign, Bonprix, bonprix partners with Brustkrebs Deutschland e. V. to raise awareness of early detection with bold new campaign, bonprix unveils knotted bra visual in awareness campaign to promote breast self-checks across Europe, breast cancer awareness, Brustkrebs Deutschland e. V., Carolin Klar, Early Detection, fashion brand, Feel ahead, Germany, International Breast Cancer Awareness Month, knotted bra, Linda Ambrosius, Malin Biernacki, Pink Collection, Renate Haidinger, self-examination, social media, Women’s Health, Wynken Blynken & Nod
(IN BRIEF) Samaritans has announced a major programme of change to strengthen its suicide prevention service, focusing on reshaping its branch network, expanding its online chat to 24/7 availability, and piloting remote volunteering opportunities. The charity, whose 23,000 volunteers answered … Read the full press release
Posted in Healthcare, Internet & Online, Ireland, Management, News, Non Profit, Society, United Kingdom
Tagged crisis support, helpline, Julie Bentley, mental health, online chat service, pathfinder branches, remote volunteering, Samaritans, Samaritans outlines major changes to ensure faster support and reach more people in crisis, Samaritans sets out future vision to reduce waiting times and expand life-saving support across the UK, Samaritans unveils transformative plans to expand support and strengthen its life-saving service, Scotland, south east England, suicide prevention, suicide prevention charity, UK, volunteer engagement, Yorkshire and Humberside
(IN BRIEF) Scientists at the University of Liverpool have developed two new handheld blood test devices that could make Alzheimer’s disease testing faster, cheaper, and more widely accessible. By combining polymer-based biosensors with AI, the devices can detect the Alzheimer’s … Read the full press release
Posted in Artificial Intelligence (AI), Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ACS Sensors, Advanced Healthcare Materials, AI, Alzheimer’s disease, AMED, artificial intelligence, biosensors, blood test, dementia, Department of Pharmacology and Therapeutics, Dr Sanjiv Sharma, Early Detection, Faculty of Health and Life Sciences, Healthcare Accessibility, Institute of Systems Molecular and Integrative Biology, low-cost diagnostics, molecularly imprinted polymers, MRC, p-tau181, Scientists at University of Liverpool develop portable blood test to expand Alzheimer’s screening access, SIMOA, UK Japan collaboration, University of Liverpool, University of Liverpool scientists pioneer affordable blood test for early Alzheimer’s detection, University of Liverpool unveils affordable handheld blood test for early Alzheimer’s detection, WHO
(IN BRIEF) Novartis, through its wholly owned subsidiary Torino Merger Sub Inc., has launched a tender offer to acquire all outstanding shares of Tourmaline Bio, Inc. at USD 48 per share in cash. The offer commenced September 29, 2025, and … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Switzerland
Tagged acquisition, biopharma acquisition, Computershare Trust Company, Hart-Scott-Rodino Act, Innisfree M&A, M&A, Merger Agreement, Novartis, Novartis Commences Tender Offer to Acquire Tourmaline Bio for USD 48 Per Share, Novartis Moves Forward with Acquisition of Tourmaline Bio Through Tender Offer, Novartis Pursues Strategic Acquisition of Tourmaline Bio with USD 48 Per Share Tender, Schedule 14D-9, Schedule TO, SEC filing, shareholder offer, tender offer, Torino Merger Sub, Tourmaline Bio, USD 48 per share
(IN BRIEF) Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which will be offered at a 55% discount off list price for cash-paying patients. Cosentyx, a biologic approved for multiple immune-mediated … Read the full press release
Posted in Healthcare, Marketing, Pharma & Biotech, Switzerland
Tagged biologics, Cosentyx, direct-to-employer model, direct-to-patient platform, discount medicines, drug affordability, DTP, hidradenitis suppurativa, immune-mediated inflammatory diseases, New Direct-to-Patient Platform from Novartis Aims to Reduce Barriers and Improve Affordability, Novartis, Novartis Launches Direct-to-Patient Platform in US with Discounted Access to Cosentyx, Novartis to Provide Patients Direct Access to Lower-Priced Cosentyx Starting November 2025, NPAF, patient access, patient assistance, psoriasis, psoriatic arthritis, secukinumab, specialty medicines, US healthcare, Victor Bultó
(IN BRIEF) The Royal Devon University Healthcare NHS Foundation Trust and the University of Exeter have launched the RAPID-IBD study to speed up diagnosis of Crohn’s disease and ulcerative colitis, conditions that affect 1 in 100 people in the UK. … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Sports, Technology, United Kingdom
Tagged Catherine Winsor, Crohn's disease, Crohn’s & Colitis UK, early diagnosis, EX postcode, Exeter City FC, gut health, IBD, inflammatory bowel disease, Jack Fitzwater, Know Your Sh*t campaign, Know Your Sh*t Campaign Backs Exeter-Led Study to Improve Early Detection of IBD in Young People, New Exeter Research Aims to Transform Diagnosis and Treatment Pathways for Crohn’s and Colitis, NIHR, patient volunteers, RAPID-IBD, RAPID-IBD Research Project Invites Volunteers to Speed Up Diagnosis of Inflammatory Bowel Disease, Royal Devon University Healthcare NHS Foundation Trust, stool test, Tariq Ahmad, Ulcerative colitis, University of Exeter
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?